Beryl Drugs Q3 Results
- BSE: 524606
- NSE: -
- ISIN: INE415H01017
- Sector: Biotechnology & Drugs
BSE
23.50
0.48 (2.09%)
0.48 (2.09%)Volume418.00
Updated: Mon 15 Jun, 2026 | 15:18:51
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Beryl Drugs Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 4.37 | 5.41 | -9.34% | 7.17 | -14.75% |
| Depreciation/ Amortization | 0.32 | 0.33 | -18.70% | 0.31 | 1.82% |
| Operating Income | -0.59 | 0.20 | 0.00% | 0.45 | 0.00% |
| Net Income | -0.17 | 0.01 | 0.00% | 0.31 | 0.00% |
| Other Operating Expenses Total | 1.22 | 1.90 | -3.47% | 3.11 | -48.10% |
| Net Income Before Taxes | -0.61 | 0.11 | 0.00% | 0.38 | 0.00% |
| Total Revenue | 3.78 | 5.61 | -26.23% | 7.62 | -28.86% |
| Selling/ General/ Admin Expenses Total | 0.79 | 0.50 | 36.81% | 0.55 | 27.25% |
| Diluted Normalized EPS | -0.33 | 0.01 | 0.00% | 0.61 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.